Downloads

  1. Predict MS Fragments For Your Compound 6/11/2026

    Rules-Based Fragment Prediction for Mass Spectrometry

    ACD/MS Fragmenter helps you predict mass spectral fragmentation in seconds. Have more confidence in your compound IDs, learn about fragmentation mechanisms, and publish your results easily.

    It’s as simple as this:

    • Draw your compound
    • Select the ionization polarity and fragmentation options
    • View its fragmentation tree
  2. Develop Chromatographic Methods Faster With Prediction Software 6/11/2026

    Your Method Development Toolbox

    ACD/Method Selection Suite is your software assistant for LC and GC method development. When you want to develop methods using Quality by Design (QbD) principles, and make every experiment count, reach for Method Selection Suite to:

    • Choose your starting conditions and columns
    • Simulate separations under new conditions
    • Optimize your chromatography with 1D, 2D, or 3D models
    • Predict the retention times of new compounds
    • Database successful methods for future use
  3. Metabolite Identification Software That Makes Decisions Easier 6/11/2026

    Understand Your Biotransformation Data

    MetaSense helps you make sense of all your metabolite identification (MetID) data. Move beyond complex workflows that have you flipping back and forth between a dozen programs.

    With a single interface for prediction, data analysis, and knowledge dashboards, make data-driven decisions swiftly.

    • Collect all your MetID data and view it in one place
    • Auto-generate biotransformation maps and kinetic plots
    • Click between interactively linked maps and plots to see your data at any depth
    • Reprocess data directly from MetaSense
    • Draw conclusions about a drug candidate’s metabolism and viability
  4. Strategic Synthesis Of ASGCT And ASCO 2026 6/10/2026

    The spring 2026 conference season made one thing obvious to those of us watching the data: the artisan era of ex vivo cellular manufacturing is finally receding.

  5. Hybridoma Services 6/5/2026

    Curia’s in vivo Discovery Immunology team offers high-performance hybridoma-based technologies to help clients discover great antibodies that make a difference.

  6. Phage And Yeast Display 6/5/2026

    Curia offers phage and eukaryotic-based yeast display platforms for in vitro discovery and engineering of potent antibody candidates for therapeutic or diagnostic use. High-affinity functional antibodies are routinely selected against a wide range of conventional or challenging targets (e.g. GPCRs) using customized or in-licensed state-of-the-art libraries.

  7. Recombinant Antibody Production 6/5/2026

    Curia has extensive experience with constructing and producing antibodies in our mammalian platforms.

  8. CHO Transient Production (TunaCHO® Process) 6/5/2026

    CHO cells have been the workhorse for protein and antibody manufacturing. The major advantages of CHO include robust growth, hardiness in suspension culture, stellar protein production and secretion, and a long track record.

  9. HEK293 Transient Production (Tuna293® Process) 6/5/2026

    HEK293 cells have been the most popular mammalian transient production platform. The primary advantage of HEK293 cells is transfection efficiency.

  10. Mammalian High-Throughput Production 6/5/2026

    The demand for high-throughput antibodies has exponentially increased over the last couple of years and has rapidly accelerated the antibody screening process.